NCT00006501View on ClinicalTrials.gov

Prognostic Significance of T Wave Alternans

CompletedOBSERVATIONAL
Enrollment

549

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

February 29, 2012

Conditions
Heart DiseasesVentricular ArrhythmiaVentricular FibrillationDeath, Sudden, CardiacHeart Arrest
Interventions
PROCEDURE

ECG

A diagnostic tool that is routinely used to assess the electrical and muscular functions of the heart (non-experimental).

Trial Locations (1)

10023

Columbia University, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Columbia University

OTHER

NCT00006501 - Prognostic Significance of T Wave Alternans | Biotech Hunter | Biotech Hunter